SA001 Low dose

DRUG2 trials

Sponsors

Samjin Pharmaceutical Co., Ltd.

Conditions

Dry Eye SyndromePrimary Sjögren's Syndrome (pSS)

Phase 2

Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.

CompletedNCT03723798

Samjin Pharmaceutical Co., Ltd.Dry Eye Syndrome

Start: 2017-11-08End: 2018-10-08Updated: 2022-03-18

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome

CompletedNCT05269810

Samjin Pharmaceutical Co., Ltd.Primary Sjögren's Syndrome (pSS)

Start: 2020-05-29End: 2022-03-21Updated: 2023-02-17